Marked disparity in incidence of bacterial infections in patients with the acquired immunodeficiency syndrome receiving interleukin-2 or interferon-gamma.

@article{Murphy1988MarkedDI,
  title={Marked disparity in incidence of bacterial infections in patients with the acquired immunodeficiency syndrome receiving interleukin-2 or interferon-gamma.},
  author={Philip G. M. Murphy and H. Clifford Lane and John I. Gallin and Anthony S. Fauci},
  journal={Annals of internal medicine},
  year={1988},
  volume={108 1},
  pages={36-41}
}
STUDY OBJECTIVE To compare the infectious complications that occurred during trials of immunomodulatory agents in patients with the acquired immunodeficiency syndrome (AIDS). DESIGN A survey of two cohorts of patients with AIDS who participated in nonrandomized, unblinded, non-placebo-controlled investigations of the toxicity and efficacy of interleukin-2 and interferon-gamma. SETTING Clinical research unit in a tertiary care center. PATIENTS Consecutive samples of 52 patients given… CONTINUE READING